This study demonstrates that elevated serum GALP (aOR 1.55) and HMGB1 (aOR 1.65) independently predict GDM development in PCOS pregnancies, with combined biomarker assessment showing superior predictive accuracy (AUC 0.84). This evidence concerns the gene HMGB1 and polycystic ovary syndrome.